PubMed

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2005 Aug;54(8):2430-5.PMID: 16046311 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.

Serebruany VL, Malinin AI, Pokov AN, Hanley DF.

Clin Ther. 2008 Feb;30(2):249-59.PMID: 18343263 [PubMed - indexed for MEDLINE]Related articles

Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.

Am J Cardiol. 2008 Aug 15;102(4):396-400. Epub 2008 May 22.PMID: 18678294 [PubMed - indexed for MEDLINE]Related articles

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.PMID: 18064330 [PubMed - indexed for MEDLINE]Related articles

Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Am J Cardiol. 2006 Jan 1;97(1):38-43. Epub 2005 Nov 7.PMID: 16377281 [PubMed - indexed for MEDLINE]Related articles

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.

Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.

Am Heart J. 2003 Oct;146(4):713-20.PMID: 14564328 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.

Angiolillo DJ, Bernardo E, Ramírez C, Costa MA, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Bass TA, Macaya C, Fernandez-Ortiz A.

J Am Coll Cardiol. 2006 Jul 18;48(2):298-304. Epub 2006 Jun 22.PMID: 16843179 [PubMed - indexed for MEDLINE]Related articles

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S.

Clin Pharmacol Ther. 2003 Mar;73(3):232-41.PMID: 12621388 [PubMed - indexed for MEDLINE]Related articles

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.

Kastrati A, von Beckerath N, Joost A, Pogatsa-Murray G, Gorchakova O, Schömig A.

Circulation. 2004 Oct 5;110(14):1916-9. Epub 2004 Jul 19.PMID: 15262828 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.

Lee BK, Lee SW, Park SW, Lee SW, Park DW, Kim YH, Lee CW, Hong MK, Kim JJ, Jang S, Chi HS, Park SJ.

Am J Cardiol. 2007 Aug 15;100(4):610-4. Epub 2007 Jun 29.PMID: 17697815 [PubMed - indexed for MEDLINE]Related articles

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.

Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.

J Am Coll Cardiol. 2006 Jan 3;47(1):27-33. Epub 2005 Dec 9.PMID: 16386660 [PubMed - indexed for MEDLINE]Related articles

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.

Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A.

J Am Coll Cardiol. 2007 Oct 16;50(16):1541-7. Epub 2007 Oct 1.PMID: 17936152 [PubMed - indexed for MEDLINE]Related articles

Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.

Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF.

Am Heart J. 2008 Jan;155(1):93.e1-7. Epub 2007 Nov 26.PMID: 18082496 [PubMed - indexed for MEDLINE]Related articles

Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.

Grau AJ, Reiners S, Lichy C, Buggle F, Ruf A.

Stroke. 2003 Apr;34(4):849-54. Epub 2003 Mar 13.PMID: 12637702 [PubMed - indexed for MEDLINE]Related articlesFree article

The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.

Saw J, Madsen EH, Chan S, Maurer-Spurej E.

J Am Coll Cardiol. 2008 Dec 2;52(23):1826-33.PMID: 19038679 [PubMed - indexed for MEDLINE]Related articles

Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.

Am J Cardiol. 2005 Oct 15;96(8):1095-9. Epub 2005 Aug 29.PMID: 16214444 [PubMed - indexed for MEDLINE]Related articles

Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.

Ahn JC, Song WH, Kwon JA, Park CG, Seo HS, Oh DJ, Rho YM.

Korean J Intern Med. 2004 Dec;19(4):230-6.PMID: 15683111 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.

Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ.

J Am Coll Cardiol. 2000 Sep;36(3):699-705.PMID: 10987587 [PubMed - indexed for MEDLINE]Related articles

Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.

Eikelboom JW, Weitz JI, Budaj A, Zhao F, Copland I, Maciejewski P, Johnston M, Yusuf S.

Eur Heart J. 2002 Nov;23(22):1771-9.PMID: 12419297 [PubMed - indexed for MEDLINE]Related articles

Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Hernández-Antolín R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Macaya C.

J Invasive Cardiol. 2004 Jun;16(6):325-9.PMID: 15156004 [PubMed - indexed for MEDLINE]Related articles